Details for New Drug Application (NDA): 075221
✉ Email this page to a colleague
NDA 075221 describes ALFENTANIL, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the ALFENTANIL profile page.
The generic ingredient in ALFENTANIL is alfentanil hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alfentanil hydrochloride profile page.
The generic ingredient in ALFENTANIL is alfentanil hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alfentanil hydrochloride profile page.
Summary for 075221
| Tradename: | ALFENTANIL |
| Applicant: | Hospira |
| Ingredient: | alfentanil hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 075221
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.5MG BASE/ML | ||||
| Approval Date: | Oct 28, 1999 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
